Jonathan Pol

38PUBLICATIONS
90CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMedical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsToxicology (incl. clinical toxicology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jun 03, 2026
Repurposing COVID-19 (and other) mRNA vaccines to boost cancer immunotherapy efficacy: mechanistic insights and future directions.

|Apr 02, 2026
Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation.

Flavia Lambertucci, Omar Motiño, Uxía Nogueira-Recalde

|Nov 28, 2025
ACBP/DBI neutralization for the prevention and treatment of malignant and non-malignant liver diseases.

Sijing Li, Flavia Lambertucci, Léa Montégut

|Aug 16, 2025
Neutralization of the autophagy-repressive tissue hormone DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein) for the treatment of hepatocellular carcinoma.

Sijing Li, Flavia Lambertucci, Isabelle Martins

|Jul 10, 2025
Disruption of cholesterol homeostasis by antidepressants induces immunogenic cell death.

Karla Alvarez-Valadez, Jonathan G Pol, Guido Kroemer

|Jun 18, 2025
Lysosomal membrane permeabilization enhances the anticancer effects of POLR1 (RNA polymerase I) transcription inhibitors.

Lucille Ferret, Jonathan G Pol, Allan Sauvat

Pageof 7

Frequent Collaborators

25 joint publications

Guido Kroemer

6 joint publications

Maria Chiara Maiuri

6 joint publications

Oliver Kepp

5 joint publications

Juliette Paillet